Supplementation of polyunsaturated fatty acids, magnesium and zinc in children seeking medical advice for attention-deficit/hyperactivity problems - An observational cohort study

Lipids in Health and Disease

Volumn 9, Issue , 2010, Pages

  Huss, Michael ^a   Völp, Andreas ^b   Stauss Grabo, Manuela ^c  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b Psy Consult Scientific Services   (Germany)

^c Engelhard Arzneimittel GmbH and Co KG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; GAMMA LINOLENIC ACID; ICOSAPENTAENOIC ACID; MAGNESIUM; ZINC; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

ABDOMINAL DISCOMFORT; ABDOMINAL DISTENSION; ABDOMINAL PAIN; ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; ATTENTION DISTURBANCE; BEHAVIOR DISORDER; CHILD; CHILD NUTRITION; CLINICAL TRIAL; DIET SUPPLEMENTATION; DIET THERAPY; DYSPEPSIA; EMOTIONAL DISORDER; FEMALE; HUMAN; HYPERACTIVITY; IMPULSIVENESS; INFECTION; INJURY; INTOXICATION; MAJOR CLINICAL STUDY; MALE; NAUSEA; NUTRITIONAL TOLERANCE; OBSERVATIONAL STUDY; PATIENT SAFETY; PRESCHOOL CHILD; PSYCHOLOGICAL RATING SCALE; QUESTIONNAIRE; RESTLESSNESS; SCHOOL CHILD; SLEEP DISORDER; SLEEP PARAMETERS; STRENGTHS AND DIFFICULTIES QUESTIONNAIRE; SWANSON NOLAN AND PELHAM SCALE; URTICARIA; VOMITING; ATTENTION; COHORT ANALYSIS; HYPERKINESIA; PARENT; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT;

ADOLESCENT; AFFECTIVE SYMPTOMS; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; HUMANS; HYPERKINESIS; IMPULSIVE BEHAVIOR; MAGNESIUM; MALE; PARENTS; PATIENT COMPLIANCE; QUESTIONNAIRES; SLEEP DISORDERS; ZINC;

EID: 77956897423     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-9-105     Document Type: Article

References (52)

1. (a). Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 2: macronutrients. JM Bourre, J Nutr Health Aging 2006 10 386 99 17066210
2. Association between maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): an observational cohort study. JR Hibbeln JM Davis C Steer, et al. Lancet 2007 369 578 585 10.1016/S0140-6736(07)60277-3 17307104 (Pubitemid 46241443)
3. Dietary supplementation with highly unsaturated fatty acids: Implications for interventions with persons with mental retardation from research on infant cognitive development, ADHD, and other developmental disabilities. N Sinn C Wilson, International Review of Research in Mental Retardation 2006 32 161 197 full-text
4. (b). Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 1: micronutrients. JM Bourre, JNutr Health Aging 2006 10 377 85
5. Nutrition in the treatment of attention-deficit hyperactivity disorder: a neglected but important aspect. R Schnoll D Burshteyn J Cea-Aravena, Appl Psychophysiol Biofeedback 2003 28 63 75 10.1023/A:1022321017467 12737097
6. Significance of long-chain polyunsaturated fatty acids (PUFAs) for the development and behaviour of children. JP Schuchardt M Huss M Stauss-Grabo A Hahn, European Journal of Pediatrics 2009 169 149 164 10.1007/s00431-009-1035-8 19672626
7. Nutrition and depression: implications for improving mental health among childbearing-aged women. LM Bodnar KL Wisner, Biol Psychiatry 2005 58 679 685 10.1016/j.biopsych.2005.05.009 16040007
8. Role of omega-3 fatty acids in brain development and function: potential implications for the pathogenesis and prevention of psychopathology. RK McNamara SE Carlson, Prostaglandins Leukot Essent Fatty Acids 2006 75 329 349 10.1016/j.plefa.2006.07.010 16949263
9. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. G Polanczyk MS de Lima BL Horta J Biederman LA Rohde, Am J Psychiatry 2007 164 942 48 10.1176/appi.ajp.164.6.942 17541055
10. How often are German children and adolescents diagnosed with ADHD? Prevalence based on the judgment of health care professionals: results of the German health and examination survey (KiGGS). M Huss H Hölling BM Kurth R Schlack, Eur Child Adolesc Psychiatry 2008 17 Suppl 1 52 58 10.1007/s00787-008- 1006-z 19132304
11. Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder. LJ Stevens SS Zental JL Deck ML Abate BA Watkins SR Lipp, et al. American Journal of Clinical Nutrition 1995 62 761 768 7572706
12. EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviours. LJ Stevens W Zhang L Peck T Kuczek A Mahon, et al. Lipids 2003 38 1007 1021 10.1007/s11745-006-1155-0 14669965
13. The Oxford Durham study: A randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder. AJ Richardson P Montgomery, Pediatrics 2005 115 1360 1366 10.1542/peds.2004-2164 15867048
14. A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties. AJ Richardson BK Puri, Progress in Neuro-Psychopharmacology and Biological Psychiatry 2002 26 233 239 10.1016/S0278-5846(01)00254-8 11817499
15. Effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit/hyperactivity disorder - a placebo-controlled double-blind study. S Hirayama T Hamazaki K Terasawa, European Journal of Clinical Nutrition 2004 58 467 473 10.1038/sj.ejcn.1601830 14985685 (Pubitemid 38443707)
16. A randomized, double-blind, placebocontrolled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder. RG Voight AM Llorente CL Jensen K Fraley MC Berretta WC Heird, Journal of Pediatrics 2001 139 189 196 10.1067/mpd.2001.116050 11487742
17. Serum zinc correlates with parent and teacher- rated inattention in children with attention-deficit/hyperactivity disorder. LE Arnold H Bozzolo J Hollway A Cook RA DiSilvestro DR Bozzolo L Crowl Y Ramadan C Williams, J Child Adolesc Psychopharmacol 2005 15 628 36 10.1089/cap.2005.15.628 16190794
18. Effect of micronutrient supplement on health and nutritional status of schoolchildren: mental function. S Vazir B Nagalla V Thangiah, et al. Nutrition 2006 22 Suppl 1 26 32 10.1016/j.nut.2004.07.021 (Pubitemid 43106680)
19. Neurological aspects of the clinical features, pathophysiology, and corrections of impairments in attention deficit hyperactivity disorder. OR Nogovitsina EV Levitina, Neurosci Behav Physiol 2007 37 199 202 10.1007/s11055-007-0001-z (Pubitemid 46453519)
20. Is there a role for n-3 long-chain polyunsaturated fatty acids in the regulation of mood and behaviour? A review of the evidence to date from epidemiological studies, clinical studies and intervention trials. KM Appleton PJ Rogers AR Ness, Nutr Res Rev 2008 21 13 41 10.1017/S0954422408998620 19079852
21. Nutrition and performance in children. G Fanjiang RE Kleinman, Curr Opin Clin Nutr Metab Care 2007 10 342 347 10.1097/MCO.0b013e3280523a9e 17414505
22. Nutrient supplementation approaches in the treatment of ADHD. JJ Rucklidge J Johnstone BJ Kaplan, Expert Rev Neurother 2009 9 461 76 10.1586/ern.09.7 19344299
23. Systematic review of national and international guidelines on ADHD. M de Seixas U Müller, European Psychiatry 2009 24 Suppl 1 395 10.1016/S0924-9338(09)70628-5 19734020
24. Nutritional and environmental approaches to preventing and treating autism and attention deficit hyperactivity disorder (ADHD): a review. LT Curtis K Patel, J Altern Complement Med 2008 14 79 85 10.1089/acm.2007.0610 18199019
25. Omega-3 fatty Acids in the Treatment of Psychiatric Disorders. M Peet C Stokes, Drugs 2005 65 1051 1059 10.2165/00003495-200565080-00002 15907142
26. Fatty acid metabolism in neurodevelopmental disorder: a new perspective on associations beetween attention-deficit/hyperactivity disorder, dyslexia, dyspraxia and the autistic spectrum. AJ Richardson MA Ross, Prostaglandins Leukot Essent Fatty Acids 2000 63 1 9 10.1054/plef.2000.0184 10970706
27. Omega-3-Fatty Acids: Evidence Basis for Treatment and Future Research in Psychiatry. MP Freemann JR Hibbeln KL Wisner JM Davies D Mischoulon M Peet PE Keck LB Marangell AJ Richardson J Lake AL Stoll, J Clin Psychiatry 2006 67 1954 1967 10.4088/JCP.v67n1217 17194275
28. The SNAP rating scale. JM Swanson W Nolan WE Pelham, Resources in Education 1982
29. Diagnostisches und Statistisches Manual Psychischer Störungen - Textrevision - DSM-IV-TR. American Psychiatric Association (APA), Diagnostic and Statistical Manual of Mental Disorders - DSM-IV-TR American Psychiatric Association, Washington, DC 2000. German version: Hogrefe, Göttingen, Sa H et al, 4 2003
30. The Strength and Difficulties Questionnaire: A Research Note. R Goodmann, Journal of Child Psychology and Psychiatry 1997 38 581 586 10.1111/j.1469-7610. 1997.tb01545.x 9255702
31. German version of the Strength and Difficulties Questionnaire (SDQ-German) - Overview and evaluation of initial validation and normative results. H Klasen W Woerner A Rothenberger R Goodman, Prax Kinderpsychol Kinderpsychiatr 2003 52 491 502 14526759
32. Omega-3/omega-6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo-controlled trial in children and adolescents. M Johnson S Ostlund G Fransson B Kadesjö C Gillberg, J Atten Disord 2009 12 394 401 10.1177/1087054708316261 18448859
33. Nutritional and dietary influences on attention deficit hyperactivity disorder. N Sinn, Nutr Rev 2008 66 558 568 10.1111/j.1753-4887.2008.00107.x 18826452
34. Cognitive effects of polyunsaturated fatty acids in children with attention deficit hyperactivity disorder symptoms: a randomised controlled trial. N Sinn J Bryan C Wilson, Prostaglandins Leukot Essent Fatty Acids 2008 78 311 26 10.1016/j.plefa.2008.04.004 18514501
35. Effects of an open-label pilot study with high-dose EPA/DHA concentrates on plasma phospholipids and behavior in children with attention deficit hyperactivity disorder. PJ Sorgi EM Hallowell HL Hutchins B Sears, Nutr J 2007 6 16 10.1186/1475-2891-6-16 17629918
36. Magnesium VitB6 intake reduces central nervous system hyperexcitability in children. M Mousain-Bosc M Roche J Rapin JP Bali, J Am Coll Nutr 2004 23 545 548
37. Improvement of neurobehavioral disorders in children supplemented with magnesium-vitamin B6. I. Attention deficit hyperactivity disorders. M Mousain-Bosc M Roche A Polge D Pradal-Prat J Rapin JP Bali, Magnes Res 2006 19 46 52 16846100 (Pubitemid 43945610)
38. Potential effects of zinc on information processing in boys with attention deficit hyperactivity disorder. O Yorbik MF Ozdag A Olgun MG Senol S Bek S Akman, Prog Neuropsychopharmacol Biol Psychiatry 2008 32 662 667 10.1016/j.pnpbp.2007.11.009 18083281
39. Effects of zinc supplementation on parent and teacher behaviour rating scores in low socioeconomic level Turkish primary school children. Y Uçkarde EN Ozmert F Unal K Yurdakök, Acta Paediatr 2009 98 731 736 10.1111/j.1651-2227.2008.01186.x 19133873
40. Role of zinc in maternal and child mental health. AM DiGirolamo M Ramirez-Zea, Am J Clin Nutr 2009 89 940 945 10.3945/ajcn.2008.26692C
41. The role of eicosanoids in the brain. D Tassoni G Kaur RS Weisinger AJ Sinclair, Asia Pac J Clin Nutr 2008 17 Suppl 1 220 228 18296342
42. An (n-3) Polyunsaturated Fatty Acid-Deficient Diet Disturbs Daily Locomotor Activity, Melatonin Rhythm, and Striatal Dopamine in Syrian Hamsters. M Lavialle G Champeil-Potokar JM Alessandri L Balasse P Guesnet C Papillon P Pévet S Vancassel B Vivien-Roels I Denis, J Nutr 2008 138 1719 1724 18716175
43. Melatonin, sleep, and circadian rhythms. FAJL Scheer CA Czeisler, Sleep Med Rev 2005 9 5 9 10.1016/j.smrv.2004.11.004 15649734
44. A systemic review of the roles of n-3 fatty acids in health and disease. ND Riediger RA Othman M Suh MH Moghadasian, J Am Diet Assoc 2009 109 668 679 10.1016/j.jada.2008.12.022 19328262
45. Co-supplementation of healthy women with fish oil and evening primrose oil increases plasma docosahexaenoic acid, gamma-linolenic acid and dihomo-gamma-linolenic acid levels without reducing arachidonic acid concentrations. J Geppert H Demmelmair G Hornstra B Koletzko, Br J Nutr 2008 99 360 369 10.1017/S0007114507801577 17678567
46. Role of docosahexaenoic acid in maternal and child mental health. U Ramakrishnan B Imhoff-Kunsch AM DiGirolamo, Am J Clin Nutr 2009 89 Suppl 958 962 10.3945/ajcn.2008.26692F
47. Polyunsaturated fatty acids in the food chain in the United States. PM Kris-Etherton DS Taylor S Yu-Poth, et al. Am J Clin Nutr 2000 71 179 188
48. Wirkstoffe funktioneller Lebensmittel in der Prävention der Arteriosklerose. B Schmitt A Ströhle BM Watkinson A Hahn, Ernährungs-Umschau 2002 49 223 229
49. Essenzielle Fettsäuren und Hirnfunktion bei Kindern. JP Schuchardt A Hahn, Deutsche Apotheken Zeitung 2008 148 56 64
50. Omega-3 LC-PUFA Supply and Neurological Outcomes in Children With Phenylketonuria (PKU). B Koletzko S Beblo H Demmelmair FL Hanebutt, Journal of Pediatric Gastroenterology and Nutrition 2009 48 2 7 10.1097/MPG. 0b013e3181977399 19172117
51. Fatty acid status and behavioural symptoms of attention deficit hyperactivity disorder in adolescents: a case-control study. AL Colter C Cutler KA Meckling, Nutr J 2008 7 8 10.1186/1475-2891-7-8 18275609
52. The treatment of Attention-Deficit/Hyperactivity Disorders with polyunsaturated fatty acids - an effective treatment alternative? J Frölich M Döpfner, Z Kinder Jugendpsychiatr Psychother 2008 36 109 116 10.1024/1422-4917.36.2.109 18622940